Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL26969058 | 0.88 | LMNA (0.37) | TDP1 | |
| SCHEMBL3229799 | 0.78 | TDP1 (0.39) | TDP1 | |
| SCHEMBL28124390 | 0.78 | TDP1 (0.39) | TDP1 | |
| SCHEMBL1135166 | 0.78 | TDP1 (0.39) | TDP1 | |
| SCHEMBL3775748 | 0.78 | TET2 (0.37) | — | |
| SCHEMBL9437899 | 0.76 | GRIK1 (0.34) | — | |
| SCHEMBL9437895 | 0.76 | GRIK1 (0.34) | — | |
| Ammonia Solution, Strong SCHEMBL3915936 | 0.76 | TDP1 (0.38) | TDP1 | |
| SCHEMBL10701254 | 0.76 | LMNA (0.42) | TDP1 | |
| SCHEMBL9126102 | 0.74 | KDM4E (0.46) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 867 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085216-A1 | EMULSION INCLUDING ACRYLIC POLYMER PARTICLES AND RELATED PROCESSES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-03-26 | — | — | US | claimed |
| EP-4590779-A1 | EMULSION INCLUDING ACRYLIC POLYMER PARTICLES AND RELATED PROCESSES | 3M Innovative Properties Company (US) | 2025-07-30 | — | — | EP | claimed |
| US-20250188321-A1 | FIRE-RETARDANT PRESSURE SENSITIVE ADHESIVES, ARTICLES, AND USES | 3M INNOVATIVE PROPERTIES COMPANY | 2025-06-12 | — | — | US | claimed |
| EP-3996692-B1 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE AGENT-CONTAINING LAYER COMPRISING A SILICONE-CONTAINING POLYMER AND A SKIN CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVE | LTS LOHMANN THERAPIE SYSTEME AG (DE) | 2025-06-11 | — | — | EP | claimed |
| CN-119923450-A | Emulsions comprising acrylic polymer particles and related methods | 3M创新有限公司 | 2025-05-02 | — | — | CN | claimed |
| EP-4493602-A1 | COMPOSITE ADHESIVES | 3M Innovative Properties Company (US) | 2025-01-22 | — | — | EP | claimed |
| US-12144899-B2 | Tetrabenazine transdermal delivery device | SHINKEI THERAPEUTICS, INC. (US) | 2024-11-19 | — | — | US | claimed |
| US-12146099-B2 | Inhibition of silica scale using a chelating agent blended with acid and alkylene oxide derived polymer dispersants | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-11-19 | — | — | US | claimed |
| US-12138353-B2 | Transdermal therapeutic system containing asenapine | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2024-11-12 | — | — | US | claimed |
| CN-118829668-A | Composite adhesive | 3M创新有限公司 | 2024-10-22 | — | — | CN | claimed |
| EP-0332860-B1 | Ethylene Vinyl Acetate-Dioctyl Maleate-2-Ethylhexyl Acrylate Interpolymers | NAT STARCH CHEM INVEST (US) | 1994-06-08 | — | — | EP | claimed |
| US-5288493-A | Containing terpolymer of alkyl acrylate or methacrylate, N-substituted alkyl acrylamide, unsaturated acid | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 1994-02-22 | — | — | US | claimed |
| US-5126189-A | Polymerizing, curing acrylated polyester urethanes and perfluorinated acrylates; laminating to fabric support; sterile barriers; diapers | GELMAN SCIENCES, INC. (US) | 1992-06-30 | — | — | US | claimed |
| WO-1991013921-A1 | METHOD OF INCORPORATING HYDROPHOBIC MONOMERS INTO ACRYLAMIDE SOLUTIONS | EXXON CHEMICAL PATENTS INC. (US) | 1991-09-19 | — | — | WO | claimed |
| EP-0282710-B1 | PRESSURE SENSITIVE ADHESIVE COMPOSITIONS FOR USE ON VINYL SUBSTRATES | National Starch and Chemical Corporation (US) | 1990-05-16 | — | — | EP | claimed |
| US-4906716-A | Method of incorporating hydrophobic monomers into acrylamide solutions | EXXON CHEMICAL PATENTS INC. (US) | 1990-03-06 | — | — | US | claimed |
| EP-0271035-A2 | Treatment of aqueous medium with copolymers containing acrylamidoalkane sulfonic acid | THE B.F. GOODRICH COMPANY (US) | 1988-06-15 | — | — | EP | claimed |
| EP-0216622-A2 | Microporous membrane laminate | GELMAN SCIENCES, INC. (US) | 1987-04-01 | — | — | EP | claimed |
| EP-0041640-B1 | PHOTOPOLYMERIZABLE COMPOSITION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-08-28 | — | — | EP | claimed |
| US-4355091-A | Polymeric neutralizing layer with temporary crosslinks from an organo-metallic crosslinking agent | POLAROID CORPORATION (US) | 1982-10-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12144899-B2 | Tetrabenazine transdermal delivery device | HTT, TTBK1, TTBK2 | TDP1 467/4885 |
| US-20260085216-A1 | EMULSION INCLUDING ACRYLIC POLYMER PARTICLES AND RELATED PROCESSES | ACR, SAAL1, AP2S1 | TDP1 942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.